Literature DB >> 35419474

Cell demise inhibited: Unexpected liaisons between mitochondria and IκΒα.

Evangelos Pazarentzos1.   

Abstract

IκΒα (the protein product of NFKBIA gene) has widely been considered a pro- apoptotic factor due to its ability to inhibit the anti-apoptotic transcription factor NFκB. Our findings indicate that IκΒα also exerts a strong anti-apoptotic activity at the outer mitochondria membrane (OMM). This function we uncovered is distinct from its ability to sequester and inhibit NFκB. IκΒα instead binds to voltage dependent anion channel 1 (VDAC1) and Hexokinase 2 (HK2), stabilizes this complex and prevents mitochondria outer membrane permeabilisation (MOMP) and apoptosis.
© 2022 Taylor & Francis Group, LLC.

Entities:  

Year:  2022        PMID: 35419474      PMCID: PMC8997252          DOI: 10.4161/23723556.2014.995020

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

1.  NF-kappa B and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappa B.

Authors:  Patricia C Cogswell; David F Kashatus; Jayne A Keifer; Denis C Guttridge; Julie Y Reuther; Cindy Bristow; Sophie Roy; Donald W Nicholson; Albert S Baldwin
Journal:  J Biol Chem       Date:  2002-11-13       Impact factor: 5.157

Review 2.  The role of VDAC in cell death: friend or foe?

Authors:  Kyle S McCommis; Christopher P Baines
Journal:  Biochim Biophys Acta       Date:  2011-10-28

Review 3.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

Review 4.  The anti-death machinery in IKK/NF-kappaB signaling.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

Review 5.  Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy.

Authors:  D J Roberts; S Miyamoto
Journal:  Cell Death Differ       Date:  2014-10-17       Impact factor: 15.828

Review 6.  Mitochondria as targets for cancer chemotherapy.

Authors:  Vladimir Gogvadze; Sten Orrenius; Boris Zhivotovsky
Journal:  Semin Cancer Biol       Date:  2008-12-03       Impact factor: 15.707

7.  Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.

Authors:  Qi Wang; Prashanth T Bhaskar; Krushna C Patra; Luke Miller; Zebin Wang; Will Wheaton; Navdeep Chandel; Markku Laakso; William J Muller; Eric L Allen; Abhishek K Jha; Gromoslaw A Smolen; Michelle F Clasquin; Brooks Robey; Nissim Hay
Journal:  Cancer Cell       Date:  2013-08-01       Impact factor: 31.743

Review 8.  No death without life: vital functions of apoptotic effectors.

Authors:  L Galluzzi; N Joza; E Tasdemir; M C Maiuri; M Hengartner; J M Abrams; N Tavernarakis; J Penninger; F Madeo; G Kroemer
Journal:  Cell Death Differ       Date:  2008-02-29       Impact factor: 15.828

9.  IκΒα inhibits apoptosis at the outer mitochondrial membrane independently of NF-κB retention.

Authors:  Evangelos Pazarentzos; Anne-Laure Mahul-Mellier; Christoph Datler; Wanwisa Chaisaklert; Ming-Shih Hwang; Jan Kroon; Ding Qize; Foy Osborne; Abdullah Al-Rubaish; Amein Al-Ali; Nicholas D Mazarakis; Eric O Aboagye; Stefan Grimm
Journal:  EMBO J       Date:  2014-10-31       Impact factor: 11.598

10.  Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.

Authors:  Amparo Wolf; Sameer Agnihotri; Johann Micallef; Joydeep Mukherjee; Nesrin Sabha; Rob Cairns; Cynthia Hawkins; Abhijit Guha
Journal:  J Exp Med       Date:  2011-01-17       Impact factor: 14.307

  10 in total
  1 in total

1.  Machine learning models identify ferroptosis-related genes as potential diagnostic biomarkers for Alzheimer's disease.

Authors:  Yanyao Deng; Yanjin Feng; Zhicheng Lv; Jinli He; Xun Chen; Chen Wang; Mingyang Yuan; Ting Xu; Wenzhe Gao; Dongjie Chen; Hongwei Zhu; Deren Hou
Journal:  Front Aging Neurosci       Date:  2022-09-28       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.